Currently holds a position at Syros Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Medical Officer | Syros Pharmaceuticals Inc | Dec. 1, 2015 - |
Chief Medical Officer | Infinity Pharmaceuticals Inc | Feb. 4, 2014 - Sept. 11, 2015 |
Senior Vice President - Clinical Development and Medical Affairs | Infinity Pharmaceuticals Inc | Sept. 4, 2013 - Feb. 4, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-05 | 2024-04-03 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
10,451
-100.0%
4.9551,732 USD |
10,451 -100.0% | 4.95 | 51,732 USD | |
2024-04-02 | 2024-04-02 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
150
-1.4%
4.98747 USD |
150 -1.4% | 4.98 | 747 USD | |
2023-12-14 | 2023-12-12 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
6,287
-100.0%
4.9531,121 USD |
6,287 -100.0% | 4.95 | 31,121 USD | |
2023-12-08 | 2023-12-06 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
6,287
-50.0%
3.9524,834 USD |
6,287 -50.0% | 3.95 | 24,834 USD | |
2023-08-02 | 2023-07-31 |
Syros Pharmaceuticals Inc
(SYRS)
|
PS Planned sale |
7,348
-100.0%
3.9529,025 USD |
7,348 -100.0% | 3.95 | 29,025 USD |